By Axel Hoos, MD, PH. D. and Kim Branson, PH. D.
The application of AI and machine learning (ML) methods has produced demonstrable results in financials, manufacturing, and other sectors. But, what about the pharma industry?
It is often claimed there is a significant difference between pharma and other sectors that prevents the adoption of ML, due to the complexity of biology and lack of large data sets.